Arkolith/Insider Trading/TYRA/Form 4

Fuhrman Alan

Chief Financial OfficerTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Nov 1, 2024
Net Buying
Open-Market Buys
$152K
Open-Market Sells
$0
Net Open-Market Flow
$152K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 30, 2024Buy(P)10K$16.00$152K13K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-120099) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML